FDA.reportPublic FDA data

bortezomib 3.5 MG in 3.5 ML Injection

RxCUI
2608952
RxNorm name
bortezomib 3.5 MG in 3.5 ML Injection
Display name
bortezomib 3.5 MG in 3.5 ML Injection
Full name
bortezomib 3.5 MG in 3.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BortezomibBORTEZOMIBMAIA Pharmaceuticals, Inc.c40e6a28-d577-43d4-bca6-bef28da1d5802021-09-22Warnings, Adverse reactionsExact identifier
rxcui: 2608952

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c40e6a28-d577-43d4-bca6-bef28da1d580bortezomib 3.5 MG in 3.5 ML Injection [PSN] · 3.5 ML bortezomib 1 MG/ML Injection [SCD] · bortezomib 3.5 MG per 3.5 ML Injection [SY]31These highlights do not include all the information needed to use BORTEZOMIB INJECTION safely and effectively.See full prescribing information for BORTEZOMIB INJECTION. BORTEZOMIB injection, for intravenous use Initial U.S. Approval: 200320210922